
What happens when a neuroscientist sits down with a standup comedian? Dr. Sillitoe joins Tosh Show with @danieltosh for a conversation that’s equal parts sharp, surprising, and genuinely funny. #cerebellum tinyurl.com/Sillitoe

We have moved on from X. Find us @cerebellumcenter.bsky.social

What happens when a neuroscientist sits down with a standup comedian? Dr. Sillitoe joins Tosh Show with @danieltosh for a conversation that’s equal parts sharp, surprising, and genuinely funny. #cerebellum tinyurl.com/Sillitoe

Huge congratulations to Sarah on successfully defending her dissertation today! Years of hard work, curiosity, and persistence have led to this moment, and we’re incredibly proud of our newly minted Dr. Donofrio! @donofrio_sarah

Our group has spent the last 15 years developing a surgical therapeutic approach called Cerebellar Deep Brain Stimulation. Here, we showed that the approach may restore brain circuit function and movement by modulating the sub-cellular structure of organelles.

Discover how @nyugrossman’s Dr. Michael E. Pacold turned a basic question about oxygen into a potential cure for a rare pediatric disease. #BehindTheBreakthrough Watch the latest episode: bit.ly/45UNk6e Head to nature for the full study: go.nature.com/45W5W5R

Just published: nature.com/articles/s41586-0… Coenzyme Q10 (CoQ10) is critical for mitochondrial function and for controlling reactive oxygen species damage to biological membranes. Because CoQ10 is poorly bioavailable, new approaches are needed to promote CoQ10 synthesis. In our latest paper @Nature, we use CoQ10 headgroup intermediates to restore CoQ10 synthesis in mouse models of HPDL encephalopathy, a rare pediatric neurodevelopmental disease driven by loss of CoQ10 headgroup synthesis. We also use CoQ10 headgroup intermediates to modify the course of this same disease in a patient. Primary CoQ10 deficiencies are rare mitochondrial disorders caused by loss of function of the enzymes that make CoQ10. The neurological symptoms of these diseases respond poorly to CoQ10, likely due to poor bioavailability of this molecule. The newest primary CoQ10 deficiency is HPDL encephalopathy, which is due to loss-of-function variants in the enzyme 4-hydroxyphenylpyruvate dioxygenase-like (HPDL). A few years ago, we discovered that HPDL carries out the first committed step of the mammalian CoQ10 headgroup synthesis pathway, in a study led by Robert Banh @BanhLab: nature.com/articles/s41586-0… We found that the enzyme HPDL makes 4-hydroxymandelate (4-HMA), the first committed precursor of 4-hydroxybenzoate (4-HB), which generates the CoQ10 headgroup. Patients with HPDL encephalopathy develop spastic paresis, and in severe cases, seizures, neurodevelopmental delay, and death. Mice lacking Hpdl recapitulate these symptoms and die by 15 days after birth. We find that treatment of Hpdl-/- mice with 4-HMA or 4-HB significantly improves the survival of mice from days to years. We treated a single patient with loss-of-function HPDL variants with 4-HB, with dramatic improvement in his symptoms. Thanks to co-authors including Robert Banh @BanhLab and Sota Kuno @kuno_sota, editors George Caputa @curiousdrgeorge and Victoria Aranda @mvicaracal, and reviewers including @RutterLab and everyone at @NYULangone @nyugrossman who made this work possible! Many thanks to our collaborators, Roy Sillitoe @BCMHouston / @TexasChildrens and Alex Joyner @MSKCancerCenter. Grateful for funding from @DamonRunyon @PershingSqFdn @psscra @MindPrize @AmericanCancer @HarringtonDI_UH @OHRareDisease @NIH.

New paper in Imaging Neuroscience by Leana King, Kevin S. Weiner, et al: Transcriptomic gradients of the human cerebellum doi.org/10.1162/imag_a_00494

The midbrain, brainstem, and cerebellum from Self Reflected. These are the reflective animations in the microetched print of this artwork, more info thorugh the link. shorturl.at/jLjYp #sciart #brain #neurology #motorcortex #neuron #neurosurgery

The cerebellum, often underestimated in its role, is crucial for driving neuroplasticity. Groundbreaking @NatureMedicine study showed that deep brain stimulation targeting the cerebellum dramatically improved motor functions in stroke patients, even three years post-stroke.

New from the lab @donofrio_sarah: Aging leads to patterned Purkinje cell loss in the cerebellum, seen in both mice and humans. More insights into how aging shapes neuronal vulnerability here: biorxiv.org/content/10.1101/…

What steps does the #brain take to satisfy #hunger? @DrYongXu1 et al uncovered new circuits and messengers involved in the process. #Metabolism @bcmhouston #GABA #dopamine blogs.bcm.edu/2025/01/23/fro…

More than 40 percent of #postdocs leave academia. Those who landed a coveted faculty position were more likely to have had a highly cited paper, changed their research topic between their #PhD and postdoc, or moved abroad after receiving their doctorate. pnas.org/doi/10.1073/pnas.24… @PNASNews -> nature.com/articles/d41586-0… #ScienceCareer

Ever joined a new lab and felt that not knowing where/what stuff is was holding your research back? Yeah, same. Kudos to Kage & Taylor from our lab for a beautiful piece in @TrendsBiochem highlighting how lab inventory systems support independence. doi.org/10.1016/j.tibs.2024.…

UCSF’s @KriegsteinLab @LiWang_neuro took a closer look at gene expression in the growing human brain and found sets of genes that could help explain autism and even adult brain cancer – revealing new possibilities for future therapies. tiny.ucsf.edu/8EHYHf

Brain cancer leverages the same tools as the developing brain 🧠! In our new study, published today in @Nature, we mapped neocortical development to explore brain cancer and neuropsychiatric risks. #stemcells #brainresearch nature.com/articles/s41586-0…

Understanding GABAergic synapse diversity and its implications for GABAergic pharmacotherapy: doi.org/10.1016/j.tins.2024.… Review on the diversity of GABAergic synapse organizer proteins

Correction: @donofrio_sarah on X